Longeveron Receives Nasdaq Extension to Regain Minimum Bid Price Compliance
Summary
Longeveron Inc. received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, pushing the deadline to September 21, 2026.
Key Events
-
Nasdaq Grants Listing Extension
Longeveron Inc. received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, setting a new deadline of September 21, 2026.
-
No Immediate Delisting
The notice confirms that there is no immediate effect on the company's continued listing status on The Nasdaq Capital Market.
-
Potential Reverse Stock Split
The company stated its intention to monitor its stock price and assess options, including a reverse stock split, if necessary, to regain compliance.
-
Ongoing Compliance Challenge
This follows an initial delisting notice on September 22, 2025, highlighting the company's persistent challenge in meeting Nasdaq's minimum bid price rule amidst broader financial concerns.
Analysis
Longeveron Inc. has been granted an additional 180 days by Nasdaq, extending its compliance period for the $1.00 minimum bid price requirement until September 21, 2026. This extension provides a temporary reprieve from immediate delisting, which is critical for a company that recently disclosed substantial doubt about its ability to continue as a going concern in its 10-K filing on March 17, 2026. While the extension avoids an immediate negative outcome, the company still faces the challenge of raising its stock price, potentially through a reverse stock split, to maintain its Nasdaq listing. This situation underscores the ongoing financial pressures and the need for strategic actions to ensure long-term viability, following a highly dilutive private placement in mid-March.
At the time of this filing, LGVN was trading at $0.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.5M. The 52-week trading range was $0.48 to $1.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.